Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
196
Value
$33.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of NBIX by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026196$33.0K<0.1%+43+28.1%AddedHolders
Q1 2026153$20.2K<0.1%+10+7.0%AddedHolders
Q4 2025143$20.3K<0.1%+6+4.4%AddedHolders
Q3 2025137$19.2K<0.1%−45−24.7%ReducedHolders
Q2 2025182$22.9K<0.1%+38+26.4%AddedHolders
Q1 2025144$15.9K<0.1%+65+82.3%AddedHolders
Q4 202479$10.8K<0.1%00.0%UnchangedHolders
Q3 202479$9.10K<0.1%00.0%UnchangedHolders
Q2 202479$10.9K<0.1%00.0%UnchangedHolders
Q1 202479$10.9K<0.1%+18+29.5%AddedHolders
Q4 202361$8.04K<0.1%00.0%UnchangedHolders
Q3 202361$6.86K<0.1%−2−3.2%ReducedHolders
Q2 202363$5.94K<0.1%00.0%UnchangedHolders
Q1 202363$6.38K<0.1%00.0%UnchangedHolders
Q4 202263$7.53K<0.1%00.0%UnchangedHolders
Q3 202263$6.69K<0.1%+2+3.3%AddedHolders
Q2 202261$5.95K<0.1%−27−30.7%ReducedHolders
Q1 202288$8.25K<0.1%+88NewHolders
Q4 20210$00.0%−15−100.0%Sold outHolders
Q3 202115$1.44K<0.1%00.0%UnchangedHolders
Q2 202115$1.46K<0.1%00.0%UnchangedHolders
Q1 202115$1.46K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.